BC
BDTX icon

Boxer Capital’s Black Diamond Therapeutics BDTX Stock Holding History

Boxer Capital’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-506,000
Closed -$2.2M – 9
2024
Q3 		$2.2M Hold
506,000
– – 0.11% 59
2024
Q2 		$2.36M Hold
506,000
– – 0.12% 51
2024
Q1 		$2.57M Hold
506,000
– – 0.13% 51
2023
Q4 		$1.42M Hold
506,000
– – 0.07% 45
2023
Q3 		$1.45M Sell
506,000
-1,508,858
-75% -$5.56M 0.08% 59
2023
Q2 		$10.2M Hold
2,014,858
– – 0.47% 48
2023
Q1 		$3.81M Hold
2,014,858
– – 0.19% 57
2022
Q4 		$3.63M Hold
2,014,858
– – 0.19% 53
2022
Q3 		$3.4M Hold
2,014,858
– – 0.19% 61
2022
Q2 		$4.96M Hold
2,014,858
– – 0.31% 51
2022
Q1 		$5.58M Hold
2,014,858
– – 0.29% 52
2021
Q4 		$10.7M Hold
2,014,858
– – 0.42% 44
2021
Q3 		$17M Hold
2,014,858
– – 0.6% 48
2021
Q2 		$24.6M Hold
2,014,858
– – 0.87% 34
2021
Q1 		$48.9M Hold
2,014,858
– – 1.66% 14
2020
Q4 		$64.6M Hold
2,014,858
– – 2.08% 12
2020
Q3 		$60.9M Hold
2,014,858
– – 2.1% 11
2020
Q2 		$84.9M Hold
2,014,858
– – 3.73% 7
2020
Q1 		$50.3M Buy
+2,014,858
New +$61.3M 3.43% 8

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Boxer Capital's BDTX Position: Q4 2024 in Review

Boxer Capital sold out of Black Diamond Therapeutics (BDTX) in Q4 2024, closing a stake of 506,000 shares — an estimated $2.2M sold.

Boxer Capital first reported a position in BDTX in Q1 2020 and held it in 19 quarters. The position peaked at $84.9M in Q2 2020. 87 funds tracked by Wall St. Rank hold BDTX as of Q4 2024.

  • Boxer Capital reported no remaining Black Diamond Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Boxer Capital sold 506,000 Black Diamond Therapeutics shares in Q4 2024, an estimated $2.2M.
  • Boxer Capital first reported a position in Black Diamond Therapeutics in Q1 2020 and held it in 19 quarters.
  • Boxer Capital's Black Diamond Therapeutics position peaked at $84.9M in Q2 2020.
  • 87 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.